您的位置: 首页 > 2023年6月 第54卷 第6期 > 文字全文
2023年7月 第38卷 第7期11
目录

肺部受累的惠普尔病与初治菌阴肺结核患者的临床特征对比分析

A comparative analysis of the clinical features between patients with pulmonary involvement of Whipple disease and primary treated bacteriological negative pulmonary tuberculosis

来源期刊: 广州医药 | 28-33 发布时间:2023-07-27 收稿时间:2025/11/13 18:33:20 阅读量:95
作者:
关键词:
惠普尔养障体肺部菌阴肺结核
Tropheryma whippleilungbacteriological negativepulmonary tuberculosis
DOI:
10.3969/j.issn.1000-8535.2023.06.005
收稿时间:
2022-12-05 
修订日期:
 
接收日期:
 
引用总数:
1  
目的 分析对比肺部受累的惠普尔病与初治菌阴肺结核患者的临床特征,提高对肺部受累的惠普尔病的认识、诊断及鉴别水平。方法 回顾性收集20例肺部受累的惠普尔病为病例组,并随机选取同期56例初治菌阴肺结核患者为对照组进行对比,探讨肺部受累的惠普尔病的临床特征。结果 病例组中老年(>37岁)、急性或亚急性的病程比例高于对照组(P<0.05)。CT影像学中,从病灶分布来看,病例组的病灶分布在下叶的病例比例高于对照组(P<0.05),病灶分布在上叶的病例比例低于对照组(P<0.05);从形态上看,病例组中表现为网状病灶、间质性肺炎的比例高于对照组(P<0.05),病例组中表现为空洞、纤维条索、实性影、结节影、树芽征、肺门淋巴结肿大的比例低于对照组(P<0.05),而性别、合并免疫力低下疾病、咳嗽、咳痰、发热、咳血、关节痛、腹泻等在组间比较差异均无统计学意义。病例组全部病例的肺泡灌洗液宏基因测序结果显示:惠普尔养障体是唯一菌19例(95.0%)或主要菌1例(5.00%,合并结核菌1序列),而对照组肺泡灌洗液宏基因测序结果显示:21例(37.5%)检测出结核分枝杆菌(TB)复合群是唯一菌或主要致病菌,18例TB-RNA(+),15例TB-LAMP(+)。结论 惠普尔病在临床可表现为急性或亚急性病程,好发中老年男性,以发热和(或)呼吸道症状为主,可伴或不伴有腹泻、关节痛;肺部影像学以下肺网状、间质性肺炎改变为主,可以单独累及肺部;与初治菌阴肺结核患者临床症状极其相似。应尽快完善支气管镜检查,肺泡灌洗液的宏基因检测对早期、快速诊断此病尤为重要。
Objective To analyze and compare the clinical features of patients with pulmonary involvement of Whipple disease and primary treated bacteriological negative pulmonary tuberculosis,so as to improve the recognition,diagnosis and differentiation ability of pulmonary involvement of Whipple disease.Methods Clinical features of Whipple disease with pulmonary involvement were investigated by retrospectively collecting 20 cases as a case group,comparing with 56 randomly selected patients with primary treated bacteriological negative pulmonary tuberculosis as a control group during the same period.Results The case group had a significantly higher proportion of older patients(>37 years),acute or subacute disease courses than the control group (P<0.05).On CT imaging,in terms of lesion distribution,the proportion of cases with lesions in the lower lobe was significantly more in the case group than in the control group(P<0.05),and the ratio of cases with lesions in the upper lobe was considerably less than in the control group(P<0.05).Regarding morphology,significantly more of the case group showed reticular lesions and interstitial pneumonia than the control group(P<0.05).Significantly fewer of the case group showed cavities,fibrous bands,solid shadows,nodular shadows,tree-bud signs,and enlarged hilar lymph nodes than the control group(P<0.05).No statistically significant differences existed between the two groups in gender,combined immunocompromising diseases,cough,sputum,fever,coughing up blood,arthralgia or diarrhea. At the same time,the differences of gender,combined immunocompromised disease,cough,sputum,fever,coughing up blood,arthralgia,and diarrhea were not statistically significant.The metagenomic sequencing of alveolar lavage fluid in the case group revealed Tropheryma whipplei as the sole pathogenic bacteria in 19 cases(95%)or the primary pathogenic bacteria in 1 case(5.00%,combined TB 1 sequence).In contrast,metagenomic sequencing of alveolar lavage fluid in the control group detected Mycobacterium tuberculosis complex as the sole or primary pathogenic bacteria in 21 cases(37.5%),TB-RNA(+)in 18 cases and TB-LAMP(+)in 15 cases.Conclusions Clinical presentation in Whipple disease can be of an acute or subacute course,preferably in middle-aged and older men,with fever or/and respiratory symptoms,either with or without diarrhea and arthralgia.Its pulmonary imaging dominates with reticular,interstitial pneumonia changes in the lower lungs,which can involve the lungs alone in the disease.At the same time,the clinical symptoms are highly similar to those patients with primary treated bacteriological negative pulmonary tuberculosis.Therefore,it is vital to complete bronchoscopy and metagenomic sequencing of alveolar lavage fluid as soon as possible for early and rapid diagnosis of this Whipple disease.Treatment with sensitive antibacterial drugs can result in significant improvement and save patients' lives.
1、 MARTH T,RAOULT D.Whipple’s disease[J].Lancet,2003,361(9353):239-246. MARTH T,RAOULT D.Whipple’s disease[J].Lancet,2003,361(9353):239-246.
2、 DUSS F R,JATON K,VOLLENWEIDER P,et al.Whipple disease:a 15-year retrospective study on 36 patients with positive polymerase chain reaction for Tropheryma whipplei[J].Clin Microbiol Infect,2021,27(6):910.e9-910.e13. DUSS F R,JATON K,VOLLENWEIDER P,et al.Whipple disease:a 15-year retrospective study on 36 patients with positive polymerase chain reaction for Tropheryma whipplei[J].Clin Microbiol Infect,2021,27(6):910.e9-910.e13.
3、 CARROLL K C,PFALLER M A,LANDRY M L.临床微生物学手册[M].王辉,马筱玲,钱渊,等,译.12版.北京:中华医学电子音像出版社,2021. CARROLL K C,PFALLER M A,LANDRY M L.临床微生物学手册[M].王辉,马筱玲,钱渊,等,译.12版.北京:中华医学电子音像出版社,2021.
4、 朱艳艳,张旭,柳澄,等 .成人初治继发性活动性肺结核的计算机断层成像特征分析[J].中华传染病杂志,2020,38(6):359-363. 朱艳艳,张旭,柳澄,等 .成人初治继发性活动性肺结核的计算机断层成像特征分析[J].中华传染病杂志,2020,38(6):359-363.
5、 DESNUES B,AL MOUSSAWI K,FENOLLAR F.New insights into Whipple’s disease and Tropheryma whipplei infections[J].Microbes Infect,2010,12(14-15):1102-1110. DESNUES B,AL MOUSSAWI K,FENOLLAR F.New insights into Whipple’s disease and Tropheryma whipplei infections[J].Microbes Infect,2010,12(14-15):1102-1110.
6、 SIERACKI J C.Whipple’s disease-observation on systemic involvement.I.Cytologic observations[J].AMA Arch Pathol,1958,66(4):464-467. SIERACKI J C.Whipple’s disease-observation on systemic involvement.I.Cytologic observations[J].AMA Arch Pathol,1958,66(4):464-467.
7、 DOLMANS R A,BOEL C H,LACLE M M,et al.Clinical manifestations,treatment,and diagnosis of Tropheryma whipplei infections[J].Clin Microbiol Rev,2017,30(2):529-555. DOLMANS R A,BOEL C H,LACLE M M,et al.Clinical manifestations,treatment,and diagnosis of Tropheryma whipplei infections[J].Clin Microbiol Rev,2017,30(2):529-555.
8、 FENOLLAR F,PONGE T,LA SCOLA B,et al.First isolation of Tropheryma whipplei from bronchoalveolar fluid and clinical implications[J].J Infect,2012,65(3):275-278. FENOLLAR F,PONGE T,LA SCOLA B,et al.First isolation of Tropheryma whipplei from bronchoalveolar fluid and clinical implications[J].J Infect,2012,65(3):275-278.
9、 中华医学会结核病学分会.肺结核诊断和治疗指南[J].中华结核和呼吸杂志,2001,24(2):5-9. 中华医学会结核病学分会.肺结核诊断和治疗指南[J].中华结核和呼吸杂志,2001,24(2):5-9.
10、 武彧,王强,王虹,等.成功救治惠普尔养障体致脓毒性休克、心搏呼吸骤停患者一例[J].中华急诊医学杂志,2021,30(9):1138-1141. 武彧,王强,王虹,等.成功救治惠普尔养障体致脓毒性休克、心搏呼吸骤停患者一例[J].中华急诊医学杂志,2021,30(9):1138-1141.
11、 STROHER C K,SANTOS A L M,CERON L,et al.Whipple’s disease:a case report in Santa Catarina,Brazil[J].Infez Med,2022,30(1):139-142. STROHER C K,SANTOS A L M,CERON L,et al.Whipple’s disease:a case report in Santa Catarina,Brazil[J].Infez Med,2022,30(1):139-142.
12、 ZHANG W M,XU L.Pulmonary parenchymal involvement caused by Tropheryma whipplei[J].Open Med(Wars),2021,16(1):843-846. ZHANG W M,XU L.Pulmonary parenchymal involvement caused by Tropheryma whipplei[J].Open Med(Wars),2021,16(1):843-846.
13、 GUO Y,LI L,LI Z,et al.Tropheryma whipplei detection by nanopore sequencing in patients with interstitial lung disease[J].Front Microbiol,2021(12):760696. GUO Y,LI L,LI Z,et al.Tropheryma whipplei detection by nanopore sequencing in patients with interstitial lung disease[J].Front Microbiol,2021(12):760696.
14、 URBANSKI G,RIVEREAU P,ARTRU L,et al.Whipple disease revealed by lung involvement:a case report and literature review[J].Chest,2012,141(6):1595-1598. URBANSKI G,RIVEREAU P,ARTRU L,et al.Whipple disease revealed by lung involvement:a case report and literature review[J].Chest,2012,141(6):1595-1598.
15、 周心怡,黄晖蓉.支气管肺泡灌洗液宏基因组学测序诊断惠普尔病1例报道并文献复习[J].2022,42(15):1176-1180. 周心怡,黄晖蓉.支气管肺泡灌洗液宏基因组学测序诊断惠普尔病1例报道并文献复习[J].2022,42(15):1176-1180.
16、 周莹,白文学.以肺炎为主要表现的惠普尔病二例[J].临床内科杂志. 2022,39(7):493-494. 周莹,白文学.以肺炎为主要表现的惠普尔病二例[J].临床内科杂志. 2022,39(7):493-494.
17、 曾灏瑜,佘德宇.以肺部感染为主的惠普尔病 1 例[J].中国感染与化疗杂志,2021,21(5):609-611. 曾灏瑜,佘德宇.以肺部感染为主的惠普尔病 1 例[J].中国感染与化疗杂志,2021,21(5):609-611.
18、 尹辛大,许明玲.惠普尔养障体重症肺炎 1 例报告[J].中国感染控制杂志,2022,21(8):812-8 15. 尹辛大,许明玲.惠普尔养障体重症肺炎 1 例报告[J].中国感染控制杂志,2022,21(8):812-8 15.
19、 马大文,王宏俊.惠普尔养障体肺炎的临床特点及诊治分析[J].首都食品与医药,2022(18):41-44. 马大文,王宏俊.惠普尔养障体肺炎的临床特点及诊治分析[J].首都食品与医药,2022(18):41-44.
20、 诸炳骅,唐菁,方荣,等.结核分枝杆菌与惠普尔养障体致肺部混合感染 1 例并文献回顾[J].贵州医药,2021,45(5):711-712. 诸炳骅,唐菁,方荣,等.结核分枝杆菌与惠普尔养障体致肺部混合感染 1 例并文献回顾[J].贵州医药,2021,45(5):711-712.
21、 王翔,谢作舟,赵金红,等.惠普尔养障体肺炎1例[J/OL].中国临床案例成果数据库,2022,4(1):e01105. 王翔,谢作舟,赵金红,等.惠普尔养障体肺炎1例[J/OL].中国临床案例成果数据库,2022,4(1):e01105.
22、 程燕,宁永忠.惠普尔养障体导致急性肺炎的探讨[J].中华检验医学杂志,2021,44(11):1090-1093. 程燕,宁永忠.惠普尔养障体导致急性肺炎的探讨[J].中华检验医学杂志,2021,44(11):1090-1093.
1、廖银光,李晓岩,钱嘉俊,等.特发性间质性肺炎(非IPF型)合并弥漫性肺泡出血综合征[J].广州医药,2024,55(06):643-647. 廖银光,李晓岩,钱嘉俊,等.特发性间质性肺炎(非IPF型)合并弥漫性肺泡出血综合征[J].广州医药,2024,55(06):643-647.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录